Synkoloid Triple Duty Joint Compound / Synko Topping

Manufacturer: Artra-Synkoloid Product Category: Joint Compound Asbestos Type: Chrysotile Years Produced: 1962–1982 Legal Classification: Tier 2 — Litigated Product

Product Description

Synkoloid Triple Duty Joint Compound and its companion product Synko Topping were interior finishing materials manufactured by Artra-Synkoloid, a company that produced a range of construction and surface preparation products during the mid-twentieth century. These joint compounds were designed as versatile drywall finishing materials intended for taping, topping, and texturing applications in residential and commercial construction. The “Triple Duty” designation reflected the product’s marketed ability to perform multiple stages of the drywall finishing process, from embedding joint tape to applying final finishing coats.

Joint compounds of this era were powder-based or pre-mixed formulations that were spread over drywall seams, fastener dimples, and surface imperfections before being sanded smooth. Synko Topping functioned specifically as a lightweight finishing compound applied during the final coats of a drywall installation, prized for its workability and the smooth surface it produced. Artra-Synkoloid marketed these products to professional tradespeople and the broader construction industry throughout the period of manufacture, which spanned from approximately 1962 to 1982.

The production timeline of these compounds coincides directly with an era in which chrysotile asbestos was a commonly incorporated additive in building materials across North America. Asbestos provided joint compounds with useful physical properties including improved binding, crack resistance, and workability, making it an attractive ingredient from a manufacturing standpoint before the health hazards of asbestos exposure were broadly regulated or disclosed to end users.

Asbestos Content

Litigation records document that Synkoloid Triple Duty Joint Compound and Synko Topping contained chrysotile asbestos as a functional ingredient during at least a portion of their production years between 1962 and 1982. Chrysotile, the most commercially prevalent form of asbestos, was incorporated into joint compound formulations throughout this era by numerous manufacturers, and plaintiffs alleged that Artra-Synkoloid’s products were no exception.

Chrysotile asbestos belongs to the serpentine mineral family and is characterized by long, curly fibers that, when disturbed, separate into fine airborne particulates capable of deep lung penetration. When used in joint compound, chrysotile was typically mixed into dry powder formulations. The asbestos fibers became bound within the dried compound matrix after application; however, that binding was not permanent. Sanding, cutting, or otherwise disturbing the cured material was documented to release respirable fibers into the work environment.

Plaintiffs in litigation involving Synkoloid and Synko Topping products alleged that the chrysotile content of these compounds was not disclosed to workers who regularly handled and applied the material, and that no adequate warnings were provided regarding the respiratory hazards associated with disturbance of the dried product.

How Workers Were Exposed

Industrial workers and construction tradespeople who handled Synkoloid Triple Duty Joint Compound and Synko Topping during the product’s years of manufacture and use faced potential asbestos exposure through several distinct pathways. Litigation records document exposure claims originating from multiple stages of product use, from initial mixing of dry powder formulations to the sanding and finishing operations that followed application.

The primary exposure risk arose during the sanding of dried joint compound. When workers sanded cured compound to achieve smooth seams and flat surfaces, the mechanical action broke apart the dried material and liberated fine dust clouds that contained respirable chrysotile fibers. In enclosed or poorly ventilated spaces — typical of active construction sites, renovation work, and interior finishing environments — this dust could remain suspended in the air for extended periods, significantly increasing the duration and concentration of potential fiber inhalation.

Secondary exposure pathways documented in litigation records include the dry mixing of powdered formulations. Workers who opened bags of dry compound and blended the product with water were exposed to airborne dust generated during that process, prior to any application or curing. Plaintiffs alleged that this mixing phase produced some of the highest dust concentrations encountered during normal product use.

Cleanup and disposal of dried compound debris, as well as incidental contact during work in spaces where others were sanding or mixing, also contributed to documented bystander exposures. Workers in adjacent trades — electricians, painters, HVAC technicians, and others present on active job sites — could be exposed to asbestos-containing dust generated by drywall finishers using these compounds without themselves ever directly handling the product.

The exposure window for these products extended beyond their production period. Synkoloid Triple Duty and Synko Topping applied during the 1960s and 1970s remained in place in existing structures for decades, meaning that renovation workers, demolition crews, and maintenance personnel continued to encounter and disturb the material well into the 1990s and beyond. Litigation records document claims from workers whose exposures occurred during renovation or remediation of buildings constructed or finished during the product’s active production years.

Documented Trust Fund / Legal Options

Artra-Synkoloid has not established a dedicated asbestos bankruptcy trust fund. As a result, there is no trust fund claims process available for individuals seeking compensation related to exposure to Synkoloid Triple Duty Joint Compound or Synko Topping. Compensation for documented injuries has been pursued through civil litigation in the tort system.

Litigation records document that individuals diagnosed with asbestos-related diseases following exposure to Synkoloid and Synko Topping products have filed personal injury and wrongful death lawsuits in state courts across the United States. Plaintiffs alleged that Artra-Synkoloid knew or should have known about the hazardous properties of chrysotile asbestos and failed to warn workers and end users about the risks associated with product use, particularly during high-dust activities such as dry mixing and sanding.

Diagnosed conditions documented in litigation involving asbestos-containing joint compounds include mesothelioma, asbestos-related lung cancer, asbestosis, and pleural disease. Individuals who worked with or around these specific Synkoloid products during their production and use years, and who have received such a diagnosis, may have standing to pursue a civil claim.

Because no dedicated trust fund exists, claimants typically pursue recovery through direct litigation against responsible parties. Individuals or surviving family members who believe exposure to Synkoloid Triple Duty Joint Compound or Synko Topping contributed to an asbestos-related illness are encouraged to consult with an attorney experienced in asbestos litigation. Documentation of work history, product identification, and medical records is critical to establishing eligibility and building a successful claim. Statutes of limitations vary by state and by disease type, and legal consultation should be sought promptly following diagnosis.